• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Carrick Doses First Patient In CT7439 Phase 1 Trial

    GLOBENEWSWIRE

    Carrick Announces First Patient Dosed in Phase 1b/2 Trial of Samuraciclib

    GLOBENEWSWIRE

    Carrick Announces First Patient Dosed in Phase 2b Clinical Trial of Samuraciclib

    GLOBENEWSWIRE

    Carrick Announces First Patient Dosed in Phase 2 Trial of Samuraciclib

    GLOBENEWSWIRE

    Carrick Therapeutics and Menarini to evaluate breast cancer combo therapy

    CLINICALTRIALSARENA

    Carrick Therapeutics and Menarini to evaluate breast cancer combo therapy

    CLINICALTRIALSARENA

    Pfizer backs $60M infusion into Carrick, teams up on breast cancer treatment

    ENDPTS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.